These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2017635)

  • 1. Adverse reactions to prolonged treatment with high doses of carbenicillin and ureidopenicillins.
    Lang R; Lishner M; Ravid M
    Rev Infect Dis; 1991; 13(1):68-72. PubMed ID: 2017635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse reactions to piperacillin in adults with cystic fibrosis.
    Stead RJ; Kennedy HG; Hodson ME; Batten JC
    Thorax; 1985 Mar; 40(3):184-6. PubMed ID: 3983886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and tolerance of azlocillin.
    Parry MF
    Arzneimittelforschung; 1985; 35(8):1292-4. PubMed ID: 4074446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
    Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
    Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of mezlocillin and carbenicillin on platelet function and thromboxane generation in patients with cancer.
    Mehta P; Lawson D; Gross S; Graham-Pole J
    Am J Pediatr Hematol Oncol; 1989; 11(3):286-91. PubMed ID: 2782554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ureidopenicillins, aztreonam, and thienamycin: efficacy as single-drug therapy of severe infections and potential as components of combined therapy.
    Winston DJ; Ho WG; Champlin RE; Gale RP; Busuttil RW
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():55-66. PubMed ID: 3086277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of mezlocillin and carbenicillin as therapy for various infectious diseases.
    Rolandi E; Barreca T; Ragni N; Valente U; Sannia A; Fontana I; Magnani G; Salvini P
    Clin Ther; 1981; 4(4):321-5. PubMed ID: 6460558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutropenia associated with mezlocillin and piperacillin.
    Kirkwood CF; Lasezkay GM
    Drug Intell Clin Pharm; 1985 Feb; 19(2):112-4. PubMed ID: 3971856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with azlocillin.
    Sanders WE
    J Antimicrob Chemother; 1983 May; 11 Suppl B():69-75. PubMed ID: 6619034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Møller NE; Høiby N
    Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of clavulanic acid on the susceptibility of Bacteroides fragilis to three acyl-ureidopenicillins, ampicillin and carbenicillin.
    Simpson CN; Maskell JP; Williams JD
    J Antimicrob Chemother; 1984 Aug; 14(2):133-8. PubMed ID: 6334069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of piperacillin versus carbenicillin for complicated urinary tract infections.
    Sharifi R; Lee M; Ojeda L
    Urol Int; 1984; 39(6):345-51. PubMed ID: 6395464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbenicillin and ticarcillin.
    Neu HC
    Med Clin North Am; 1982 Jan; 66(1):61-77. PubMed ID: 7038341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of extended-spectrum penicillins in infants and children.
    Wilson CB; Koup JR
    J Pediatr; 1985 Jun; 106(6):1049-56. PubMed ID: 3889255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
    Eliopoulos GM; Moellering RC
    Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pyocyanea infection in orthopedic surgery and its treatment].
    Zenker H
    Z Orthop Ihre Grenzgeb; 1972 Oct; 110(5):610-4. PubMed ID: 4264227
    [No Abstract]   [Full Text] [Related]  

  • 18. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa meningitis treated with an azlocillin combination.
    Davidson S; Yellin EO; Shaked I; Rubinstein E
    Infection; 1982; 10 Suppl 3():S168-9. PubMed ID: 6818154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes.
    Basker MJ; Edmondson RA; Sutherland R
    Infection; 1979; 7(2):67-73. PubMed ID: 108220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.